Ireland
--:--IST
Recruiting Observational

Retrospective Register for Uveal Melanoma

NCT05733728 · tracked via the Priya Life Science Austria tracker
Phase
Observational
Started
2023-01-23
Last updated
2023-05-06

Condition(s) studied

Uveal Melanoma

Investigational drug(s) / intervention(s)

any therapy suitable

any therapy suitable: any therapy suitable

Study summary

Background: Uveal melanoma (UM) is a common primary ocular malignancy associated with limited overall survival in the advanced stage of the disease. Fundamental breakthrough regarding the management of the disease and the overall-survival have not yet been achieved. Studies with large cohorts are difficult to perform due to limited patient numbers, therefore retrospective analyses are of great potential to gain further knowledge in a disease with high clinical needs.

Aim: The proposed project is a register for patients with UM treated at the Department of Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021.

Patients and Methods: Patients treated for UM at the Department of Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021 will be included in the register. Information on the baseline characteristics, survival times and course of the disease will be gathered via retrospective chart review and saved in a password-secured database.

Eligibility

Sex
ALL
Min age
18 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria * Patients 18 - 99 years * Diagnosis of uveal melanoma Exclusion Criteria * Patients younger than 18 years of age * Inadequate or missing information on the clinical course in patient charts

Primary outcome measure(s)

  • Conduction of a Register providing the basis for — 1997-2021
    Retrospective studies analyzing the obtained data and easy identification of patients for prospective studies (e.g. long-term survival analysis)

Trial sites (1)

FacilityCityRegionStatus
Medical University of Vienna Vienna Austria Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05733728 on ClinicalTrials.gov ↗ ← All trials in Austria